Retham Technologies, Inc.
Wauwatosa, WI
- UEI
- KDM9HGS7NFT9
- CAGE
- 7VR31
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1225 Discovery Pkwy #260a, Wauwatosa, WI 53226, USA
- Website
- rethamtechnologies.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
SBA capabilities narrative
Develop In vitro diagnostics
Quick answers
Is Retham Technologies, Inc. registered in SAM.gov?
Yes. Retham Technologies, Inc.'s SAM.gov registration is active through July 27, 2027.
What is Retham Technologies, Inc.'s most recent federal award?
Retham Technologies, Inc.'s most recent federal grant award is An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with… (R44HL147734), from National Heart Lung and Blood Institute (NIH), on June 15, 2019.
On GovTribe
See Retham Technologies, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors